Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.
Rambo, good summary of Alan's approach, why would he change it when it's funding his lifestyle. I disagree that right now they should look too far beyond ava6k.
They have a lovely poster, brochures available, for affimers calling out why they're superior. It's achieved nothing. They could produce the same for precision, now rebranded for a comparison against ADCs, showing how great the platform is. They need a commercial product out there proving it. Switching the pipeline to compete with ADCs isn't cheap, they're spending a lot on R&D. Personally I'd rather see them do that once they're self sustaining rather than diluting.
‘despite recent successes’. ADCs don’t sound that successful when you compare them to AVA6k and the bloke whose main complaint is having the rigmarole of having to traipse in for treatment as he’s feeling on top of the world. That’s a success.
Evening, that slide was the clear highlight for me. Very well communicated as the previous Alan explainer didn’t make it clear that it works perfectly for both mid and high fap. Opens up lots of opportunities for the proven platform.
Have been shopping…. $1bn for preclinical. Thanks to Rah for sharing on twatter.
https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-buy-radiology-specialist-mariana-oncology-1-billion-2024-05-02/
Lolz a plenty if one of the options that’s back on the table is agreeing to a takeover. I’d suggest a bit more than $1bn given platform technologies and being in the clinic. You could imagine Alan digging his heels in and you could imagine Chris thinking a quick payday could work out nicely.
I don't think Apicel is irrelevant to Abakta, it still holds a value. If the value can be unlocked then it's a winner. There could be a bigger appetite for investing over there and we can gain from it. If not, nothing ventured....
I imagine it’s an option. Apicel aren’t having around though, it be fascinating to see how it gets on in the clinic. An IPO could serve the same purpose, a chance to retain some ownership and get some capital for Tx coffers.
He didn't like the Paul Hill interview as Paul went off script and asked him about the commercial strategy - for clout obviously. Not only did Alan have a face like thunder he stumbled and thoroughly embarrassed himself - not a good sign for a CEO. Whatever, he's gone.
I’ve been critical for years, thank you. No issues with the M&A, it’s the original Dx that’s drained the cash - Alan’s pet project. It’s no shock that Tx needs cash on an ongoing basis, if we could have raised at a 10% discount, why didn’t we? I blame Alan, he had PI cash on the table and chose to grease city boys to get what he views as a prestige name on the register. Unless Bella’s theories are right, it’s looking like he was led by his ego. He was delighted by courting Sequoia Carpets, it meant nowt to the business. If they were strategic partners and willing to provide on going cheap finance, kudos to him. They weren’t, we’re just a punt for them. If it’s sold for £1bn, it’s a massive failure.
I’d be fascinated by a discussion thread on the general board with all trades posted as they happen.
Otherwise, I imagine some dribbling window lickers with a set of crayons absolutely love the painting by numbers series from the catastrophically failed gambler.